Abstract
Oncologic outcomes after minimally invasive segmentectomy or lobectomy in patients with hypermetabolic clinical stage IA1-2 non-small cell lung cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have